Article Information
History
- February 8, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- A. Capalbo1,*,
- M. Poli1,
- L. Rienzi2,
- L. Girardi1,
- D. Cimadomo2,
- F. Benini3,
- A. Farcomeni4,
- J. Cuzzi5,
- C. Rubio6,7,
- E. Albani8,
- L. Sacchi8,
- A. Vaiarelli2,
- I. Vogel9,
- E. Hoffmann9,
- C. Livi3,
- P.E. Levi-Setti8,
- F.M. Ubaldi2 and
- C. Simón6,7,10,11
- 1Igenomix, Reproductive Genetics, Marostica, Italy
- 2Clinica Valle Giulia, GeneraLife IVF, Rome, Italy
- 3DEMETRA, GeneraLife IVF, Florence, Italy
- 4Department of Economics and Finance University of Rome “Tor Vergata”
- 5Igenomix US & Canada – Miami, FL, USA
- 6Igenomix, Valencia, Spain
- 7Igenomix Foundation, Reproductive Genetics, Valencia, Spain
- 8IRCCS, Humanitas Research Hospital, Division of Gynecology and Reproductive Medicine, Fertility Center, Rozzano (Milan), Italy
- 9DNRF Center for Chromosome Stability, Department of Cellular and Molecular Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark
- 10Valencia University and INCLIVA, Department of Obstetrics and Gynecology, Valencia, Spain
- 11School of Medicine- Harvard University- MA- USA, Department of Obstetrics and Gynecology, Boston, U.S.A.
- ↵* Corresponding author; email: antcapalbo{at}gmail.com
Posted February 08, 2021.
A prospective double-blinded non-selection trial of reproductive outcomes and chromosomal normalcy of newborns derived from putative low/moderate-degree mosaic IVF embryos
